RXO Inc Analysts Average $16.07 Target, Stephens Sees 6.25% Downside; RS Rating Rises
Analysts maintain a consensus Hold rating on RXO with a weighted average 12-month target price of $16.07, while Stephens assigns a $15 target implying a 6.25% downside from $16. The stock’s relative strength rating climbed to 74, suggesting improving technical momentum.
1. Analyst Ratings and Price Targets
On February 9, Stephens set a $15 price target for RXO Inc, implying a 6.25% downside from a $16 share price. Nineteen research firms collectively maintain a Hold rating with an average 12-month target of $16.07, as Citigroup lowered its neutral target to $15, Truist cut its buy target to $18, UBS held neutral, and Zacks moved to a strong sell.
2. Technical Momentum Improves
The stock’s relative strength rating rose to 74, indicating that RXO has outperformed 74% of stocks over the past 12 months. Intraday trading ranged between $15.76 and $17.40, reflecting heightened interest in momentum.
3. Trading Range and Market Metrics
RXO Inc’s 52-week high is $22.17 and its low is $10.43, with a market capitalization of approximately $2.64 billion. Average daily volume stands near 2.4 million shares, underscoring active trading levels.